There are about 6,100 hospitals in the United States, and the market that trades them has never been busier or more unsettled. Kaufman Hall counted 56 hospital transactions announced in the first nine months of 2026 — already more than the 46 announced in all of 2025. The first quarter alone produced 22 deals and $14.5 billion in transacted revenue, the strongest first quarter since 2020.
Every one of those deals began with the same question: what is this hospital worth? Boards ask it before they vote. Buyers ask it before they bid. Lenders ask it before they lend. Bankruptcy courts ask it before they approve a sale. And the answer is not a guess — it is a professional opinion, built from discounted cash flow, market multiples, and the value of the underlying assets, and defended against regulators who treat an inflated number as a legal problem.
That is what this name does. It is not a metaphor and it is not a play on words. “Hospital valuation” is the exact term for valuing a hospital in a sale or merger — business valuation, not real-estate appraisal — and it is the phrase a hospital CEO, a health-system CFO, and a private-equity deal partner all type into a search box when they need the work done.
Specific, and broad enough to travel. A strong hospital-valuation brand must serve four buyers at once: the valuation firms that write the opinions, the M&A advisors who run the sales, the hospital systems that buy and sell, and the private-equity firms that now own hundreds of American hospitals. This name serves all four without narrowing to any one of them.
